Newcardio, Inc. (NWCI)

[H8ster]

Notable Presentations over the past 3 months:
1. In November, NewCardio presented at Cambridge Healthtech Institute’s Mitigating Safety Risks in Early Clinical Development conference in Philadelphia. Presentations by NewCardio and others supported adopting automated algorithms for ECG analysis.

2. In October, NewCardio was invited by the FDA to present at the Diabetic Drug Safety Conference meeting entitled "Development of Type 2 Diabetes Mellitus Drugs: State-ofthe-Art Cardiovascular Safety Assessments" in Washington DC. Dr. Ihor Gussak’s
presentation, entitled "Quantitative 3-dimensional Electrocardiography Substantially Improves Diagnosis of Acute Coronary Syndromes in Type II Diabetic Patients,"
demonstrated that my3KG is 42% more accurate than the 12-lead ECG in diagnosing Acute Myocardial Infarction in diabetic patients, with equal or better specificity.

3. The August 2010 issue of Heart Rhythm published a study, entitled
"Vectorcardiographic and Electrocardiographic Criteria to Distinguish New and Old Left Bundle Branch Block." This study was performed by Beth Israel Deaconess Medical Center and the Harvard Clinical Research Institute, in collaboration with NewCardio.
Results demonstrated 100% sensitivity and 96% specificity in distinguishing old versus new left bundle branch block, which is an essential element in directing cardiac intervention.